These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

290 related items for PubMed ID: 8304048

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Bisphosphonate space measurement in Paget's disease of bone treated with APD.
    Stone MD, Marshall DH, Hosking DJ, Perkins AC, Evans AJ, Wastie ML.
    J Bone Miner Res; 1992 Mar; 7(3):295-301. PubMed ID: 1316715
    [Abstract] [Full Text] [Related]

  • 6. Rapid, divergent changes in spinal and forearm bone density following short-term intravenous treatment of Paget's disease with pamidronate disodium.
    Price RI, Gutteridge DH, Stuckey BG, Kent GN, Retallack RW, Prince RL, Bhagat CI, Johnston CA, Nicholson GC, Stewart GO.
    J Bone Miner Res; 1993 Feb; 8(2):209-17. PubMed ID: 8442439
    [Abstract] [Full Text] [Related]

  • 7. Long-term control of bone turnover in Paget's disease with zoledronic acid and risedronate.
    Hosking D, Lyles K, Brown JP, Fraser WD, Miller P, Curiel MD, Devogelaer JP, Hooper M, Su G, Zelenakas K, Pak J, Fashola T, Saidi Y, Eriksen EF, Reid IR.
    J Bone Miner Res; 2007 Jan; 22(1):142-8. PubMed ID: 17032148
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [The treatment of Paget's disease of bone with second-generation bisphosphonates via intravenous infusion].
    Arboleya L, Sánchez J, Iglesias G, Arranz JL.
    Rev Clin Esp; 1993 Dec; 193(9):467-71. PubMed ID: 8108576
    [Abstract] [Full Text] [Related]

  • 11. Improved treatment of Paget's disease with dimethylaminohydroxypropylidene bisphosphonate.
    Schweitzer DH, Zwinderman AH, Vermeij P, Bijvoet OL, Papapoulos SE.
    J Bone Miner Res; 1993 Feb; 8(2):175-82. PubMed ID: 8442435
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The effects of intravenous alendronate in Paget's disease of bone.
    O'Doherty DP, McCloskey EV, Vasikaran S, Khan S, Kanis JA.
    J Bone Miner Res; 1995 Jul; 10(7):1094-100. PubMed ID: 7484285
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Sustained biochemical effects of short treatment of Paget's disease of bone with dichloromethylene diphosphonate.
    Chapuy MC, Charhon SA, Meunier PJ.
    Metab Bone Dis Relat Res; 1983 Jul; 4(6):325-8. PubMed ID: 6229683
    [Abstract] [Full Text] [Related]

  • 19. Paget's disease of bone treated in five days with AHPrBP (APD) per Os.
    Thiébaud D, Jaeger P, Burckhardt P.
    J Bone Miner Res; 1987 Feb; 2(1):45-52. PubMed ID: 3455156
    [Abstract] [Full Text] [Related]

  • 20. Pamidronate infusions for the treatment of Paget's disease of bone.
    Mazieres B, Ahmed I, Moulinier L, Bon E, Cantagrel A, Laroche M.
    Rev Rhum Engl Ed; 1996 Jan; 63(1):36-43. PubMed ID: 9064108
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.